Pathogenic Transdifferentiation of Th17 Cells Contribute to Perpetuation of Rheumatoid Arthritis during Anti-TNF Treatment.
about
Anti-inflammatory effects of interleukin-23 receptor cytokine-binding homology region rebalance T cell distribution in rodent collagen-induced arthritis.Pathogenic IL-23 signaling is required to initiate GM-CSF-driven autoimmune myocarditis in mice.Multifaceted role of IL-21 in rheumatoid arthritis: Current understanding and future perspectives.Survivin co-ordinates formation of follicular T-cells acting in synergy with Bcl-6.The role of IL-23 receptor signaling in inflammation-mediated erosive autoimmune arthritis and bone remodeling.IL-23R Deficiency Does Not Impact Atherosclerotic Plaque Development in Mice.The Anti-Inflammatory Mediator, Vasoactive Intestinal Peptide, Modulates the Differentiation and Function of Th Subsets in Rheumatoid Arthritis
P2860
Q37362521-61ADF4E7-9AC7-4982-AF1A-3175BF23CF99Q37498070-D224BEBA-C941-4975-8746-1CFDEA8E24B4Q38638262-A7F1176C-BCBE-4E53-848E-FC196E313195Q43164202-A25213C4-597C-498E-BFAD-1E75019DAE18Q48283709-61C74364-BF47-447B-B6EE-17C1F07D2842Q55418732-80F7BFFA-AF75-4BB3-8C91-20F7803D073DQ58805868-E7CEDD3E-6ADA-4332-9FB0-88752FFCAB66
P2860
Pathogenic Transdifferentiation of Th17 Cells Contribute to Perpetuation of Rheumatoid Arthritis during Anti-TNF Treatment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pathogenic Transdifferentiatio ...... tis during Anti-TNF Treatment.
@ast
Pathogenic Transdifferentiatio ...... tis during Anti-TNF Treatment.
@en
type
label
Pathogenic Transdifferentiatio ...... tis during Anti-TNF Treatment.
@ast
Pathogenic Transdifferentiatio ...... tis during Anti-TNF Treatment.
@en
prefLabel
Pathogenic Transdifferentiatio ...... tis during Anti-TNF Treatment.
@ast
Pathogenic Transdifferentiatio ...... tis during Anti-TNF Treatment.
@en
P2093
P2860
P50
P1433
P1476
Pathogenic Transdifferentiatio ...... tis during Anti-TNF Treatment.
@en
P2093
Karin M E Andersson
Maria I Bokarewa
Mikael Brisslert
Nicola Filluelo Cavallini
Sofia Silfverswärd
Vijay K Kuchroo
P2860
P2888
P304
P356
10.2119/MOLMED.2015.00057
P407
P577
2015-06-04T00:00:00Z
P6179
1068965745